Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS · Delayed Price · Currency is USD
0.5000
0.00 (0.00%)
Nov 6, 2026, 4:00 PM EST
Vicapsys Life Sciences Market Cap
Vicapsys Life Sciences has a market cap or net worth of $16.19 million as of November 9, 2026. It is the 38,187th most valuable company in the world and the 5,286th biggest in the United States. Its market cap has decreased by 66.67% in one year.
Market Cap
16.19M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#5,286 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 5, 2018, Vicapsys Life Sciences's market cap has increased from 1.33M to 16.19M, an increase of 1,113.55%. That is a compound annual growth rate of 32.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 16.19M | 50,580,056.25% |
| Dec 10, 2024 | 32.00 | -100.00% |
| Dec 20, 2023 | 87.88M | 8,285.51% |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cell Source | 35.80M |
| ZIVO Bioscience | 23.91M |
| Provectus Biopharmaceuticals | 22.27M |
| Biomind Labs | 19.41M |
| Inhibitor Therapeutics | 13.73M |
| Synlogic | 12.56M |
| Brainstorm Cell Therapeutics | 12.48M |
| Hepion Pharmaceuticals | 11.98M |